NCT00992381View on ClinicalTrials.gov

Comparison Study of a New Combination of 2 Marketed Medications (Esomeprazole and Naprosyn) Versus Naprosyn Alone

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2009

Study Completion Date

October 31, 2009

Conditions
Healthy
Interventions
DRUG

PN400

500mg Naproxen and 20mg esomeprazole

DRUG

Naprosyn

500mg Naproxen

Trial Locations (1)

Unknown

Research Site, Brisbane

Sponsors

Lead Sponsor

AstraZeneca

Collaborators (1)

POZEN
All Listed Sponsors
collaborator

POZEN

INDUSTRY

lead

AstraZeneca

INDUSTRY